IP Library Patent Application 12192871
Patent Application
App. No. 12/192,871

HIGH CONCENTRATION LOCAL ANESTHETIC FORMULATIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/192,871
Abstract

A transdermal topical anesthetic formulation, which can be used to ameliorate or inhibit neuropathic pain, has been developed. In the preferred embodiment, the topical anesthetic is a local anesthetic such as lidocaine, most preferably lidocaine free-base in a gel, and the dosage of the local anesthetic is effective in the painful area or immediately adjacent areas, to ameliorate or eliminate the pain. High concentration of local anesthetic in solution in the carrier is used to drive rapid release and uptake of the drug. Relief is typically obtained for a period of several hours.

Claims (12)

1 . A formulation for treating pain comprising

a local anesthetic in a lotion, cream, spray, foam, dispersion, gel, or ointment, wherein the local anesthetic is present in an amount from greater than 20% by weight.

2 . The formulation of claim 1 wherein the local anesthetic is selected from the group consisting of dibucaine, bupivacaine, etidocaine, tetracaine, lidocaine, and xylocaine.

3 . The formulation of claim 2 wherein the local anesthetic is lidocaine free base.

4 . The formulation of claim 1 wherein the formulation is a gel or other continuous phase.

5 . The formulation of claim 1 wherein the local anesthetic is present in an amount between greater than 20% and 40% by weight.

6 . The formulation of claim 1 wherein the local anesthetic is present in an amount of approximately 40% by weight.

7 . The formulation of claim 1 wherein the formulation is a lotion, cream, gel, foam, suspension, dispersion or spray.

8 . The formulation of claim 1 providing an initial burst release within six hours of administration.

9 . The formulation of claim 1 wherein the concentration of the local anesthetic is sufficiently high that release is governed by the Third Law of Thermodynamics, not simple diffusion.

10 . A method of treating pain comprising administering to a site of or adjacent to the pain an effective amount of the formulation of any of claim 1 - 9 .

11 . The method of claim 10 wherein the pain is neuropathic pain.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2014
From: ARCION THERAPEUTICS, INC.
To: VALLINEX, INC.
Reel/Frame 032506/0561 →
MERGER Recorded Mar 24, 2014
From: VALLINEX, INC.
To: CENTREXION I, INC., C/O CENTREXION CORPORATION
Reel/Frame 032506/0570 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2008
From: CAMPBELL, JAMES N.; MICHAELIS, ARTHUR F.
To: ARCION THERAPEUTICS, INC.
Reel/Frame 021578/0736 →